Inquest Medical Research

Products And Services

• Daybreak Obesity and Hunger Clinical Trial

  The DAYBREAK Study is looking at how safe an investigational medication is and whether it works for people with rare forms of obesity. Multiple genes play an important role in how hungry you feel and the amount of energy you use. When there are changes (variants) in one or more of these genes, this may cause insatiable hunger, which may lead to obesity. This study will look at whether an investigational medication can restore the body’s ability to control weight in people with certain genetic variants and obesity.

• Heartburn Clinical Trial

  Do You Suffer From Symptomatic Non-Erosive Gastroesophageal Reflux Disease? A Clinical Trial Might Be An Option For You! The purpose of this study, which involves research, is to determine whether the investigational drug, vonoprazan, is safe and effective in the potential treatment of symptomatic non-erosive gastroesophageal reflux disease compared to a placebo.

• Diabetes Type 2 Clinical Trial

  Metformin is a common treatment for controlling high blood sugar in patients with type 2 diabetes. However, due to safety considerations, the current formulations of metformin are often not prescribed to type 2 diabetes patients who also have advanced chronic kidney disease. The purpose of this study is to test an investigational formulation of metformin called Metformin Delayed Release (DR). It is designed to be absorbed in the small intestine rather than the stomach. This study will evaluate whether the DR formulation could reduce systemic exposure to metformin and lead to fewer side effects for type 2 diabetes patients with chronic kidney disease.

• COPD Clinical Trial

  The RPL554-CO-301 Study is looking at a potential new medication (investigational medication) to see how safe it is and whether it works for people with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD). The study will help us learn whether the investigational medication is able to reduce swelling and widen the airways of the lungs in a single medication.